Skip to content
hcg-service-hero-1

Insights From Halloran

Sheila GwizdakMar 7, 2024 12:14:00 PM7 min read

Quality Governance and Evolution of Quality Management Review 

Quality governance can be defined as an overarching framework that provides assurance of ...
Start Reading
Michael Fusakio, PhDMar 1, 2024 12:14:00 PM5 min read

Preparing Now for FDA START Program for Rare Disease Drug Developers 

On September 29, 2023, the U.S. Food and Drug Administration (FDA) took action to help ...
Start Reading
Meaghan PowersFeb 28, 2024 12:20:00 PM5 min read

Small Biotech and Pharma Dilemma – Three Steps to Remain Competitive on a Budget 

While attending the annual SCOPE summit this year, listening to sessions and walking the ...
Start Reading
Laura GilliamFeb 27, 2024 8:56:00 AM5 min read

Pulling the Thread on FDA’s Master Protocol Draft Guidance 

The U.S. Food and Drug Administration’s (FDA) draft guidance, Master Protocols for Drug ...
Start Reading
Halloran Consulting GroupFeb 22, 2024 12:21:00 PM9 min read

5 Broad Implications for Project Optimus: Future of Oncology Trials

Oncology drug development is different from most drug development programs in other ...
Start Reading
Halloran Consulting GroupFeb 15, 2024 12:16:00 PM8 min read

Reconsidering the 3+3 Dose Escalation in Oncology Studies

Many product developers are propelled by the goal of delivering life-saving treatments as ...
Start Reading
Rashida ChallengerFeb 15, 2024 11:45:00 AM3 min read

Trial Rescue: Leadership Approach Propels Clinical Development

Situation
Start Reading
Halloran Consulting GroupJan 24, 2024 12:05:00 PM2 min read

Why The FDA Modernization Act 2.0 is The Challenge Our Industry Needs 

Shawn Roach, one of Halloran’s Regulatory Chemistry, Manufacturing, and Controls (CMC) ...
Start Reading
Halloran Consulting GroupJan 16, 2024 11:31:00 AM6 min read

Navigating the Patient Clinical Trial Training Matrix

Content in collaboration with ScienceMedia Authors: Malachi Bierstein, Chief Commercial ...
Start Reading
Halloran Consulting GroupJan 10, 2024 12:21:00 PM4 min read

The Value of Artificial Intelligence to Support Inspection Readiness   

A Health Authority (HA) inspection of a clinical trial can occur at any time, and ...
Start Reading